BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37295337)

  • 1. Assessment of anterior pituitary reserve capacity based on growth hormone response to growth hormone-releasing peptide-2 test in the elderly.
    Teramoto S; Tahara S; Hattori Y; Kondo A; Morita A
    Growth Horm IGF Res; 2023 Aug; 71():101545. PubMed ID: 37295337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative growth hormone (GH) peak values during a GH releasing peptide-2 test reflect the severity of hypopituitarism and the postoperative recovery of GH secretion in patients with non-functioning pituitary adenomas.
    Soga A; Fukuda I; Kobayashi S; Tahara S; Morita A; Sugihara H
    Endocr J; 2020 Feb; 67(2):167-175. PubMed ID: 31776295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin hypoglycemia test and releasing hormone (corticotropin-releasing hormone and growth hormone-releasing hormone) stimulation in patients with pituitary failure of different origin.
    Stalla GK; Losa M; Oeckler R; Müller OA; von Werder K
    Horm Res; 1988; 29(5-6):191-6. PubMed ID: 2851521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single growth hormone (GH) determination is sufficient for the diagnosis of GH-deficiency in adult patients using the growth hormone releasing hormone plus growth hormone releasing peptide-6 test.
    Leal A; Lage M; Popovic V; Torres E; Koppeschaar HP; Paramo C; Micic D; Garcia-Mayor RV; Dieguez C; Casanueva FF
    Clin Endocrinol (Oxf); 2002 Sep; 57(3):377-84. PubMed ID: 12201831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of pituitary-adrenal responsiveness between insulin tolerance test and growth hormone-releasing peptide-2 test: a pilot study.
    Kano T; Sugihara H; Sudo M; Nagao M; Harada T; Ishizaki A; Nakajima Y; Tanimura K; Okajima F; Tamura H; Ishii S; Shibasaki T; Oikawa S
    Peptides; 2010 Apr; 31(4):657-61. PubMed ID: 20045717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH.
    Arvat E; di Vito L; Maccagno B; Broglio F; Boghen MF; Deghenghi R; Camanni F; Ghigo E
    Peptides; 1997; 18(6):885-91. PubMed ID: 9285939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ghrelin, growth hormone-releasing peptide-6, and growth hormone-releasing hormone on growth hormone, adrenocorticotropic hormone, and cortisol release in type 1 diabetes mellitus.
    de Sá LB; Nascif SO; Correa-Silva SR; Molica P; Vieira JG; Dib SA; Lengyel AM
    Metabolism; 2010 Oct; 59(10):1536-42. PubMed ID: 20189610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults.
    Popovic V; Leal A; Micic D; Koppeschaar HP; Torres E; Paramo C; Obradovic S; Dieguez C; Casanueva FF
    Lancet; 2000 Sep; 356(9236):1137-42. PubMed ID: 11030292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hexarelin as a test of pituitary reserve in patients with pituitary disease.
    Korbonits M; Kaltsas G; Perry LA; Grossman AB; Monson JP; Besser GM; Trainer PJ
    Clin Endocrinol (Oxf); 1999 Sep; 51(3):369-75. PubMed ID: 10469018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of growth hormone-releasing peptides in healthy dogs and in dogs with pituitary-dependent hyperadrenocorticism.
    Bhatti SF; De Vliegher SP; Van Ham L; Kooistra HS
    Mol Cell Endocrinol; 2002 Nov; 197(1-2):97-103. PubMed ID: 12431802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
    Van den Berghe G; de Zegher F; Bowers CY; Wouters P; Muller P; Soetens F; Vlasselaers D; Schetz M; Verwaest C; Lauwers P; Bouillon R
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone-releasing peptide-6 stimulates sleep, growth hormone, ACTH and cortisol release in normal man.
    Frieboes RM; Murck H; Maier P; Schier T; Holsboer F; Steiger A
    Neuroendocrinology; 1995 May; 61(5):584-9. PubMed ID: 7617137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index.
    Corneli G; Di Somma C; Baldelli R; Rovere S; Gasco V; Croce CG; Grottoli S; Maccario M; Colao A; Lombardi G; Ghigo E; Camanni F; Aimaretti G
    Eur J Endocrinol; 2005 Aug; 153(2):257-64. PubMed ID: 16061832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The GH, prolactin, ACTH and cortisol responses to Hexarelin, a synthetic hexapeptide, undergo different age-related variations.
    Arvat E; Ramunni J; Bellone J; Di Vito L; Baffoni C; Broglio F; Deghenghi R; Bartolotta E; Ghigo E
    Eur J Endocrinol; 1997 Dec; 137(6):635-42. PubMed ID: 9437229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between insulin tolerance test, growth hormone (GH)-releasing hormone (GHRH), GHRH plus acipimox and GHRH plus GH-releasing peptide-6 for the diagnosis of adult GH deficiency in normal subjects, obese and hypopituitary patients.
    Cordido F; Alvarez-Castro P; Isidro ML; Casanueva FF; Dieguez C
    Eur J Endocrinol; 2003 Aug; 149(2):117-22. PubMed ID: 12887288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the clinical significance of the growth hormone-releasing peptide-2 test for the diagnosis of secondary adrenal failure.
    Arimura H; Hashiguchi H; Yamamoto K; Shinnakasu A; Arimura A; Kikuchi A; Deguchi T; Habu M; Fujio S; Arita K; Nishio Y
    Endocr J; 2016 Jun; 63(6):533-44. PubMed ID: 27020037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased GH secretion and enhanced ACTH and cortisol release after ghrelin administration in Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6) and GHRH.
    Correa-Silva SR; Nascif SO; Lengyel AM
    Pituitary; 2006; 9(2):101-7. PubMed ID: 16832586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ipamorelin, the first selective growth hormone secretagogue.
    Raun K; Hansen BS; Johansen NL; Thøgersen H; Madsen K; Ankersen M; Andersen PH
    Eur J Endocrinol; 1998 Nov; 139(5):552-61. PubMed ID: 9849822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone/insulin-like growth factor-1 response to acute and chronic growth hormone-releasing peptide-2, growth hormone-releasing hormone 1-44NH2 and in combination in older men and women with decreased growth hormone secretion.
    Bowers CY; Granda-Ayala R
    Endocrine; 2001 Feb; 14(1):79-86. PubMed ID: 11322505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ghrelin, GH-releasing peptide-6 (GHRP-6) and GHRH on GH, ACTH and cortisol release in hyperthyroidism before and after treatment.
    Molica P; Nascif SO; Correa-Silva SR; de Sá LB; Vieira JG; Lengyel AM
    Pituitary; 2010 Dec; 13(4):315-23. PubMed ID: 20602173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.